Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3997295 | Revista Colombiana de Cancerología | 2009 | 9 Pages |
Abstract
Nearly half of breast cancer patients in developing countries present with a locally advanced cancer. Treatment is centered on a multimodal approach based on chemotherapy, surgery and radiotherapy. The growing use of neoadjuvant chemotherapy has led to a more conservative surgical approach; nonetheless, it is not yet considered as a standard. There are no clear recommendations on the use of a radiotherapy boost in such situation. A Medline search was developed. Most articles are retrospective series. Survival free of locoregional relapse in patients treated with neoadjuvant chemotherapy, breast conserving surgery and radiotherapy is good. All articles described a boost administered to nearly all patients without regard to their prognostic factors, given that a locally advanced tumor is already considered as a poor prognostic factor. Even tough the poor level of evidence, a recommendation can be made: radiotherapy boost should be administered to all patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and breast conserving surgery
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Ricardo Cendales, Rosalba Ospino, Felipe Torres, Martha Cotes,